A New Look at a Seasoned Solution:

Improving Outcomes in Bipolar I Disorder with Long-Acting Injectable Antipsychotics

Supported by

Supported by an educational grant from Otsuka America Pharmaceutical, Inc. and Lundbeck.

Faculty

Christoph Correll, MD

Professor of Psychiatry, Chair Child and Adolescent Psychiatry, The Zucker Hillside HospitalDonald and Barbara Zucker School of Medicine at Hofstra/NorthwellThe Feinstein Institutes for Medical ResearchCharité - Universitätsmedizin Berlin Zucker School of Medicine at Hofstra/NorthwellLong Island, NY

Brooke Kempf, MSN, PMHNP-BC

Hospitalist, Hamilton Center CMHCAdjunct Faculty, Indiana University of IndianapolisIndianapolis, IN